Trajenta is a medication containing Linagliptin. It is commonly used for Chronic Conditions. Available at affordable prices from MedsBase with worldwide shipping.

What are the side effects of Trajenta?

DPP-4 inhibitors are among the best-tolerated oral antidiabetics. Most side effects are mild and similar across the class. Common: Upper respiratory tract infection, nasopharyngitis Headache Mild GI upset — nausea, diarrhoea (less common than with metformin) Uncommon but important: Acute pa...

How can I order Trajenta online?

You can order Trajenta online from MedsBase with worldwide shipping. We supply WHO-GMP certified generic medications produced by licensed pharmaceutical manufacturers.

What is the recommended dosage of Trajenta?

Standard dose: 5 mg once daily — one fixed dose regardless of renal or hepatic function. Trajenta can be taken with or without food. Once-daily dosing (twice for vildagliptin) — pick a consistent time. Half-life and excretion: > 100 hours (long terminal half-life); ~80% excret...

Trajenta

✅ Manages blood sugar levels
✅ Supports diabetes treatment
✅ Improves insulin function
✅ Once-daily dosing option
✅ Enhances glycemic control

Trajenta contains Linagliptin

SKU: Trajenta Categorie: Prezentare generală a categoriei, Afecțiuni cronice, Diabet, Medicamente pentru diabet Etichetă: Linagliptin

✓ Verificat medical de Morgan Ellis — Cercetător farmaceutic · 8 ani de experiență · Ultima recenzie: mai 2026

Plată criptată

Plățile în crypto reduc prețul cu 10%

Livrare discretă în întreaga lume

1.400+ clienți · 50+ țări

⚡ Quick Answer — What is Trajenta?

Trajenta is a brand of linagliptin (5 mg), a DPP-4 inhibitor (dipeptidyl peptidase-4 inhibitor, also called a “gliptin”) used for type 2 diabetes. It works by blocking the enzyme DPP-4, which normally breaks down incretin hormones (GLP-1 and GIP). Higher incretin levels stimulate insulin release and suppress glucagon only when blood glucose is high — so DPP-4 inhibitors produce a glucose-dependent effect and do not cause hypoglycaemia as monotherapy. HbA1c reduction: 0.6–0.8 points. Weight-neutral. Once-daily dosing (most gliptins). Only DPP-4 that does primește, need dose adjustment in renal impairment — one tablet, one dose, any kidney function. Cardiovascular-neutral in CARMELINA and CAROLINA outcome trials. Dose: 5 mg once daily — one fixed dose regardless of renal or hepatic function. Main side effects are mild — upper respiratory symptoms, headache, rare pancreatitis. Avoid in type 1 diabetes and DKA.

Ce beneficii oferă MedsBase: Producător certificat WHO-GMP · Ambalaj discret · Livrare la nivel mondial · Peste 1.400 de recenzii verificate ale clienților

📦 Fiecare comandă este acoperită de politica noastră de Politica noastră de Reexpediere Garantată — dacă coletul dumneavoastră nu sosește în 20 de zile lucrătoare, îl relivrăm.

De ce să comanzi de la MedsBase

Medicamentele noastre generice sunt procurate de la producători certificați WHO-GMP și expediate la nivel mondial în ambalaje discrete și simple — fără denumirea medicamentului pe exteriorul coletului. Plățile cu cardul sunt procesate printr-un procesor reglementat (descrierile de pe extrasul de cont includ un procesor de plăți cu card reglementat — niciodată “MedsBase” sau numele vreunui medicament). Acceptăm și criptomonede și transferuri bancare SEPA. Fiecare comandă este susținută de Politica noastră de Asigurare pentru Relivrare.

What Is Trajenta?

Trajenta is an oral antidiabetic medicine containing linagliptin (5 mg), manufactured by Boehringer Ingelheim. Available in packs of 30, 60, 90 or 180 tablets. It is prescribed for adults with type 2 diabetes, usually alongside metformin or as a second- or third-line agent.

linagliptin belongs to the DPP-4 inhibitor (“gliptin”) class — first approved 2011 (originator brand: Trajenta, Boehringer Ingelheim / Eli Lilly). Gliptins are widely used because they are weight-neutral, have a low hypoglycaemia risk, and can be used across the renal spectrum with appropriate dose adjustment.

How Does Trajenta Work?

After meals, the gut releases two incretin hormones — GLP-1 (glucagon-like peptide-1) și GIP (glucose-dependent insulinotropic peptide). These hormones tell the pancreas to release insulin and the liver to suppress glucagon, but they are rapidly broken down by the enzyme dipeptidyl peptidase-4 (DPP-4) within minutes.

linagliptin blocks DPP-4. This raises active GLP-1 and GIP levels, producing:

Glucose-dependent insulin release from pancreatic beta cells — only when blood glucose is elevated
Suppression of glucagon from alpha cells, reducing hepatic glucose output after meals
Modest slowing of gastric emptying

Because insulin release is glucose-dependent, DPP-4 inhibitors do not cause hypoglycaemia on their own. Typical HbA1c reduction: 0.6–0.8 percentage points. Weight effect: neutral. Blood pressure and lipid effects: neutral.

Doza și administrare

Standard dose: 5 mg once daily — one fixed dose regardless of renal or hepatic function. Trajenta can be taken with or without food.

Once-daily dosing (twice for vildagliptin) — pick a consistent time.
Half-life and excretion: > 100 hours (long terminal half-life); ~80% excreted unchanged via the biliary/faecal route — only about 5% renal.
Renal dosing: No dose adjustment needed at any eGFR — linagliptin is the DPP-4 of choice for CKD, including dialysis.
No hepatic dose adjustment for most gliptins (vildagliptin needs baseline ALT check).
Miss a dose — skip it; take the next at the usual time. Do not double up.

Efecte Secundare

DPP-4 inhibitors are among the best-tolerated oral antidiabetics. Most side effects are mild and similar across the class.

Frecvente:

Upper respiratory tract infection, nasopharyngitis
Dureri de cap
Mild GI upset — nausea, diarrhoea (less common than with metformin)

Uncommon but important:

Acute pancreatitis — rare but documented class effect; stop immediately if severe abdominal pain develops
Severe joint pain (arthralgia) — can occur weeks to months after starting; usually resolves on discontinuation
Hypersensitivity / angioedema — bullous pemphigoid has been reported; stop if blistering skin lesions develop
Saxagliptin specifically: small increase in hospitalisation for heart failure
Vildagliptin specifically: rare hepatic enzyme elevations — monitor ALT

As monotherapy, hypoglycaemia is very rare. When combined with sulfonylureas or insulin, those agents’ doses may need reducing.

Interacțiuni medicamentoase

Sulfonylureas, insulin, meglitinides — additive glucose-lowering. Expect to reduce these doses when adding a gliptin.
Strong CYP3A4/5 inhibitors (ketoconazole, clarithromycin, ritonavir, atazanavir) — raise saxagliptin levels; halve the saxagliptin dose. Minimal effect on sitagliptin, linagliptin, vildagliptin.
Rifampicin — reduces linagliptin levels modestly; effect may be clinically meaningful.
Inhibitori ACE — theoretical additive angioedema risk; clinical significance debated.
Digoxină — small rise in peak level with sitagliptin; usually not clinically important.

Who Should Not Take Trajenta?

Type 1 diabetes mellitus
Diabetic ketoacidosis
Known hypersensitivity to linagliptin or other DPP-4 inhibitors
History of pancreatitis (relative — discuss alternatives)
Pregnancy and breastfeeding — data limited; alternatives preferred
Saxagliptin specifically: severe heart failure
Vildagliptin specifically: ALT or AST > 3× upper limit of normal

Depozitare

Store Trajenta below 30°C in a dry place, in the original blister. Keep out of reach of children.

Întrebări frecvente

Is Trajenta the same as linagliptin?

Yes. Trajenta contains the same active ingredient as the originator brand. Bioequivalence is required by regulatory authorities, so clinical effect is the same at the same dose.

Why choose linagliptin over sitagliptin?

Linagliptin’s main advantage is that it does not need dose adjustment in kidney disease — the same 5 mg tablet works whether eGFR is 90 or 15. Sitagliptin has a larger outcome-trial dataset but requires 50% or 75% dose cuts in moderate-to-severe CKD. For patients with stable renal function, the two are clinically similar.

Will Trajenta cause low blood sugar?

On its own, no. DPP-4 inhibitors act in a glucose-dependent manner — they only augment insulin release when blood glucose is high. Hypoglycaemia only becomes a concern when Trajenta is combined with a sulfonylurea, meglitinide, or insulin.

Does Trajenta cause weight gain?

No — DPP-4 inhibitors are weight-neutral. This is one of the main reasons they are preferred over sulfonylureas in overweight patients.

Can Trajenta cause pancreatitis?

Acute pancreatitis is a rare but documented class effect. The absolute risk is small, and large trials (TECOS, CARMELINA, SAVOR) have generally shown no statistically significant excess. Stop immediately and seek medical attention if severe abdominal pain develops — especially pain radiating to the back.

How long does Trajenta take to work?

Fasting glucose starts to fall in the first week. Maximal HbA1c effect is at 12 weeks. If HbA1c has not fallen by at least 0.3–0.5% after 3 months, a different second agent (SGLT-2 inhibitor or GLP-1 agonist) should be considered.

Can I stop Trajenta suddenly if I don’t feel well?

Yes — DPP-4 inhibitors can be stopped abruptly without rebound hyperglycaemia. If you develop severe abdominal pain, skin blistering, or severe joint pain, stop and contact your doctor.

Where can I buy Trajenta online?

You can order Trajenta (5 mg) from MedsBase in packs of 30, 60, 90 or 180 tablets. We ship worldwide, with discreet packaging and genuine WHO-GMP certified manufacturer stock.

Related Diabetes Medications

⚕ Dezaprobare medicală. This page is for informational purposes only and does not replace medical advice from a qualified healthcare professional. DPP-4 inhibitors are associated with rare pancreatitis, severe joint pain, and bullous pemphigoid — always use under medical guidance and stop with prompt review if these occur.